Neratinib for Breast Cancer, Adjuvant User Reviews (Page 2)
Brand names: Nerlynx
Neratinib has an average rating of 5.5 out of 10 from a total of 19 reviews for the treatment of Breast Cancer, Adjuvant. 42% of reviewers reported a positive experience, while 32% reported a negative experience.
Reviews for Neratinib
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
Learn more about Breast Cancer, Adjuvant
Care guides
More about neratinib
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: EGFR inhibitors
- En español
Nerlynx (neratinib) "Started on low dosage from mid-Jan, minor diarrhea on 2/3 days due to increased dosage and a bit more severe diarrhea after heavy meals. Finger-crossed for remaining days on Nerlynx"